First degenerative scoliosis surgery performed at Nizwa Hospital
Dr. Sultan Saif Al Kalbani, Head of the Spine Unit at Khoula Hospital, Consultant in Orthopedic and Spine Surgery, and leader of the medical team, explained to Oman News Agency (ONA) that the surgery was performed on a patient suffering from an abnormal curvature of the spine, using the latest surgical techniques.
He clarified that degenerative scoliosis occurs in elderly patients due to the deterioration of cartilage, joints, and ligaments in the back, leading to curvature and severe back pain during movement. He noted that this type of scoliosis differs from the scoliosis that affects children.
Dr. Al-Kalbani emphasised that this accomplishment is the result of joint coordination between Khoula Hospital, the national reference center for spine surgeries, and Nizwa Hospital, in line with the Ministry of Health's strategy to enhance specialised services across various governorates of the Sultanate of Oman and reduce pressure on central referral hospitals.
He pointed out that such procedures were previously conducted outside the governorate, imposing financial and psychological burdens on patients and their families. However, localising these services helps alleviate these challenges and promotes equitable healthcare distribution among governorates. He also highlighted the importance of collaboration between health institutions to exchange expertise and build national competencies capable of performing complex surgeries.
Dr. Al-Kalbani noted the Spine Unit's commitment to advancing spine surgery services in accordance with the latest global practices, with a focus on continuous training and upskilling of medical personnel.
It is worth mentioning that Khoula Hospital serves as a centre for treating all types of scoliosis.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Times of Oman
a day ago
- Times of Oman
Operation Chivalrous Knight 3 delivers medicines, medical supplies to support Gaza's health sector
Gaza: The UAE, in cooperation with the World Health Organisation (WHO) in the Gaza Strip, has delivered a shipment of medicines and medical supplies to the health sector, as part of Operation Chivalrous Knight 3. The aid will be distributed to hospitals and medical facilities to help address acute shortages and strengthen their ability to respond to emergencies. Among the recipients was Nasser Medical Complex in Khan Younis, which received several truckloads carrying essential medicines and critical supplies. The delivery aims to boost the hospital's capacity to handle urgent cases at a time when it is facing severe shortages of medicines and equipment. Sharif Al-Nayrab, Media Director for Operation Chivalrous Knight 3 in Gaza, reaffirmed that the UAE continues to provide medical aid and pharmaceuticals to the Gaza Strip under the initiative to prevent the collapse of the healthcare system and alleviate the suffering of hospitals and patients. Heba Alnajjar, Emergency medical teams (EMT) coordinator at WHO, stated that the organisation delivered the shipment to the Palestinian Ministry of Health, containing all essential and currently unavailable medicines in Gaza's health facilities. She expressed hope for continued cooperation and the entry of more UAE aid to support the health sector. Ibrahim Al-Farra, Director of the Palestinian Aid Delivering Committee at the Ministry of Health in Gaza, described the UAE's assistance as a "lifeline" for all patients, noting that the continued supply of medicines and medical equipment revitalises hospitals and helps save the lives of the sick and wounded. The delivery is part of an ongoing series of aid shipments scheduled for the coming period, as part of the UAE's sustained efforts through Operation Chivalrous Knight 3 to ease the health crisis in Gaza and ensure the continuity of medical services.
Times of Oman
2 days ago
- Times of Oman
Agreement inked to provide low-income segments with home ventilators
Muscat: The Ministry of Health on Thursday signed a funding agreement with Oman India Fertilizer Company (OMIFCO) to purchase ventilators for patients from low-income and social security segments. The agreement was signed by Saud Amer Al Nudhairi, the Ministry's Director General of Financial Affairs, and Khalid Mohammed Al Fannah Al Araimi, OMIFCO's Director of Sustainability and Institutional Communication. Al Nudhairi stressed the importance of partnerships between the government sector and other sectors in the Sultanate of Oman to serve members of the public. He hailed the company's noble initiative which, he observed, has been undertaken for the sixth time in a row. For his part, Al Araimi expressed his appreciation for the Health Ministry's ongoing partnership in supporting needy segments of society. The devices minimises the need for hospitalisation, improves the quality of life for patients and provides better monitoring and control of health conditions. They are an essential part of some home care programmes as they provide a safe and sustainable option for some patients who require long-term mechanical ventilation outside the hospital.
Times of Oman
3 days ago
- Times of Oman
10,000 patients benefit from early retinopathy screening programme in various governorates
Muscat: The National Programme for Early Detection of Diabetic Retinopathy using artificial intelligence (AI) technologies has successfully screened over 10,000 eligible patients. This achievement reflects the programme's rapid implementation and its impact on preventing retinopathy complications and protecting diabetic patients from the risk of vision loss. The AI-powered national screening programme has expanded its services to 25 health centres across all governorates of the Sultanate of Oman. This expansion is part of national efforts to enhance ophthalmology services, leverage modern technologies, and utilise AI to support early diagnosis and ensure timely access to screening and treatment. Dr. Majid Salim Al Shaibani, Retina and Intraocular Inflammation Consultant at Al Nahdha Hospital and Operational Director of the National Diabetic Retinopathy Screening Program, told Oman News Agency (ONA): 'Since the programme's nationwide launch, we have screened over 10,000 patients in less than six months, detecting numerous retinopathy cases at early stages before noticeable symptoms appeared." He added that preliminary data indicates a detection rate exceeding 30% of screened cases—a level of effectiveness unattainable before the introduction of AI technologies. Dr. Al Shaibani explained that diabetic retinopathy is a silent disease in its early stages, often diagnosed only after serious complications arise. Early detection enables prompt intervention, whether through close monitoring, laser treatment, or intraocular injections, significantly reducing the risk of progression to advanced stages that may cause permanent blindness. This aligns with global recommendations to prevent diabetes-related blindness. Regarding referral mechanisms, he noted that the programme is electronically linked to the national health records system (Shifa), allowing detected cases requiring further evaluation or treatment to be directly referred to specialised eye clinics in reference hospitals. Priority is determined based on severity to ensure urgent cases receive timely care. He pointed out that the program utilizes globally approved AI systems for retinal image analysis, capable of detecting various stages of diabetic retinopathy. These advanced deep-learning algorithms provide results within seconds of image capture. The AI models were trained on hundreds of thousands of high-quality global images and validated across diverse populations, with local verification conducted at Oman's dedicated reading center to ensure clinical accuracy. Dr. Al Shaibani highlighted plans to develop a localised AI database incorporating demographic and epidemiological characteristics to improve diagnostic precision. The program also coordinates with periodic diabetes check-ups, integrating retinopathy screening with other essential tests (e.g., diabetic foot exams, kidney function, blood pressure) into a single visit for patient convenience. He underlined awareness campaigns targeting diabetic patients through clinic staff, electronic reminders, social media, and educational materials to stress the dangers of delayed screening. Parallel community outreach initiatives aim to increase participation and encourage pre-symptomatic testing. As the third country globally to implement such an AI-driven initiative, Oman demonstrates its commitment to adopting cutting-edge technologies for enhanced diagnostic accuracy, cost efficiency, and timely intervention. The programme covers all Type 1 and Type 2 diabetes patients, playing a pivotal role in preventing vision loss through early detection.
